Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian stock markets open weak.
Tue, 3 Mar 09:30 am

The major Asian equity markets have opened the day on mixed note with China market (down 0.9%) and Japan market (down 0.2%), leading the losses. However, stock markets in Singapore (up 0.7%) and Hong Kong (up 0.03%) have opened on a positive note. With the Crude oil prices increased nearly 2.8% and are trading at Rs 3,150 per barrel. Precious metals, gold and silver have witnessed marginal movements. While gold prices have increased marginally by 0.1% at Rs 26,600 per 10 grams, silver is prices has declined marginally by 0.2% and is trading at 36,650 per kilogram.

Indian stock markets have opened today's trading session on a negative note. BSE Sensex and NSE-Nifty have lost 0.05% each in the early morning trade. BSE Mid Cap and BSE Small Cap continue to outperform the market with gains of 0.6%, each. Among the sectoral indices, the auto and metal stocks are witnessing maximum selling pressures. The Indian Rupee is trading at 61.89.

Today's market is weighed by poor economic numbers that reveals slowdown in sector growth for the month of January. As per the financial daily, the core sector growth declined nearly 1.8% for the month of January. The eight core sectors that contribute about 40% to the Indian economy include coal, crude oil, fertiliser, refinery products, natural gas, steel, electricity and cement. Two sectors that led to fall in core sector growth were crude oil production and natural gas production. Each of the sector growth fell 2.3% and 6%, respectively.

Indian Pharmaceutical sector has gained amidst negative sentiment. Natco pharma and Ipca labs are among the leading gainers in the pack. Sun pharmaceuticals has announced about acquisition of Opiates owned by GSK in Australia. The business comprises of materials used in analgesics. The business transaction is expected to complete in August 2015. Sun pharma is trading up by 2%

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

View all commentaries | Archives

Read the latest Market Commentary


Equitymaster requests your view! Post a comment on "Indian stock markets open weak.". Click here!

  
ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.